VOR
Vor Biopharma Inc.
NASDAQ · Healthcare · Biotechnology · US
$21.40
−2.24%0
Insider buys (3m)
1
Insider sells (3m)
-$4.2K
Net value (3m)
+43.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 26, 2026 | RA CAPITAL MANAGEMENT, L.P. · 10 percent owner | M-Exempt | 1,500 | $3.74 |
| Jul 21, 2026 | RA CAPITAL MANAGEMENT, L.P. · 10 percent owner | Sale | 213 | $20 |
| Jul 9, 2026 | ZACCARDELLI DAVID · director | A-Award | 42,658 | $20 |
| Jun 12, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | A-Award | 57,162 | $14 |
| Jun 12, 2026 | Beckman Daniella · director | A-Award | 53,283 | $14 |
| Jun 12, 2026 | Levin Andrew David · director | A-Award | 57,162 | $14 |
| Jun 12, 2026 | Cumbo Alexander · director | A-Award | 56,345 | $14 |
| Jun 12, 2026 | Kalir Erez · director | A-Award | 57,162 | $14 |
| Jun 12, 2026 | Joustra Wouter · director | A-Award | 57,162 | $14 |
| Jun 12, 2026 | Namouni Fouad · director | A-Award | 56,549 | $14 |
| Jun 12, 2026 | Detheux Michel · director | A-Award | 57,162 | $14 |
| Apr 24, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Sale | 165,150 | $16 |
| Apr 21, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Sale | 171,963 | $16 |
| Apr 21, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Sale | 458,411 | $16 |
| Apr 15, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Sale | 153,735 | $16 |
| Apr 15, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Sale | 53,644 | $16 |
| Apr 15, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Sale | 530,610 | $16 |
| Apr 10, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Sale | 135,201 | $17 |
| Apr 10, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Sale | 130,862 | $17 |
| Apr 10, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Sale | 828 | $16 |
| Apr 10, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Sale | 353,242 | $16 |
| Apr 6, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Sale | 258,475 | $18 |
| Apr 6, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Sale | 537,754 | $17 |
| Apr 6, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Sale | 44,728 | $17 |
| Apr 6, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Sale | 1,525 | $19 |
| Apr 6, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Sale | 6,775 | $19 |
| Dec 19, 2025 | Levin Andrew David · director | A-Award | 3,000 | $13 |
| Dec 19, 2025 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | A-Award | 3,000 | $13 |
| Dec 19, 2025 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | A-Award | 4,625,346 | $11 |
| Dec 19, 2025 | Joustra Wouter · director | A-Award | 3,000 | $13 |
Institutional positioning
13F filings over the trailing two quarters
New 74Increased 59Reduced 32Sold out 17
| Filer | Action | Shares | Filed |
|---|---|---|---|
| TCG CROSSOVER MANAGEMENT, LLC | New Position | 5,673,078 | May 15, 2026 |
| TCG Crossover Management, LLC | Unchanged | 5,673,078 | Aug 14, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 5,404,998 | May 15, 2026 |
| FMR LLC | Increased | 4,932,149 | Aug 13, 2026 |
| FCPM III SERVICES B.V. | Unchanged | 4,117,354 | Aug 14, 2026 |
| FCPM III SERVICES B.V. | Increased | 4,117,354 | May 15, 2026 |
| BlackRock, Inc. | Increased | 3,468,107 | Aug 7, 2026 |
| VR ADVISER, LLC | Increased | 3,041,719 | May 15, 2026 |
| VR Adviser, LLC | Unchanged | 3,041,719 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 2,616,336 | Aug 7, 2026 |
| Frazier Life Sciences Management, L.P. | Unchanged | 2,543,939 | Aug 14, 2026 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | Unchanged | 2,543,939 | May 15, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Reduced | 2,402,095 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 2,084,328 | Aug 13, 2026 |
| Caligan Partners LP | Unchanged | 1,925,066 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 26, 2026